Kevin Kuykendall, CEO of Vivione Biosciences, Discusses Startup Companies (Exec Q&A)

by Mark Carter  on Monday, May. 7, 2012 12:00 am  

Kevin Kuykendall, CEO of Vivione Biosciences

Kevin Kuykendall is the new chief executive at Vivione Biosciences, a Little Rock startup formerly known as Litmus Rapid-B.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.